ASPIRE BIOPHARMA HOLDINGS, INC. Loss Contingency, Damages Sought, Value
ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP) had Loss Contingency, Damages Sought, Value of $1.00 million as of 2026-06-29, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:LossContingencyDamagesSoughtValue · last filed 2026-08-13
- 2026-06-29: Loss Contingency, Damages Sought, Value $1.00M.
- 2026-04-30: Loss Contingency, Damages Sought, Value $1.00M.
| Period end | Loss Contingency, Damages Sought, Value |
|---|---|
| 2026-06-29 | $1.00M 10-Q · filed 2026-08-13 |
| 2026-04-30 | $1.00M 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |